Using real time quantitative PCR, we confirmed that CHI3L1 and FOXM1 were significantly up regulated (P<0.05, T test) and confirmed that NRGN and L1CAM were significantly down regulated (P<0.05, T test) in GBM compared to normal brain tissues (Figure 2). The gene discussed is FOXM1; the disease is glioblastoma.